Gotowa bibliografia na temat „Pied diabétique – Ulcères – Photothérapie”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Pied diabétique – Ulcères – Photothérapie”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Pied diabétique – Ulcères – Photothérapie":
Niclot, J., A. Stansal, A. Galloula, I. Lazareth i P. Priollet. "Des ulcères de jambe et du pied chez un patient diabétique révélant une leishmaniose cutanée". Journal des Maladies Vasculaires 39, nr 2 (marzec 2014): 145. http://dx.doi.org/10.1016/j.jmv.2013.12.071.
Chanson-Höglund, Helena, Derek Christie, Mathieu Assal i Emilien Jeannot. "Expérience clinique d’une orthèse de décharge pour prévenir et guérir les ulcères digitaux du pied diabétique". Revue Médicale Suisse 17, nr 725 (2021): 315–19. http://dx.doi.org/10.53738/revmed.2021.17.725.0315.
Sebti, S., O. Liazidi, A. Amari i M. Rachedi. "Apport de l’appareillage dans le traitement des ulcères plantaires du pied diabétique neuropathique. À propos de 120 patients". Annals of Physical and Rehabilitation Medicine 57 (maj 2014): e382. http://dx.doi.org/10.1016/j.rehab.2014.03.1389.
Silvin, Marie-Agnès, Pierre-Yves Benhamou, Danielle Tirard-Gatel i Marie Muller. "Conception d’un outil de e-learning pour la prise en charge des ulcères de pied chez le patient diabétique". Diabetes & Metabolism 43, nr 2 (marzec 2017): A119. http://dx.doi.org/10.1016/s1262-3636(17)30448-2.
Kamgain Simeu, L. S., A. Mjabber, N. E. Haraj, S. El Aziz i A. Chadli. "Place des injections de plasma riche en plaquettes autologue dans la prise en charge des ulcères du pied diabétique (résultats préliminaires)". Annales d'Endocrinologie 84, nr 1 (luty 2023): 207. http://dx.doi.org/10.1016/j.ando.2022.12.343.
Ha Van, G. "Traitement des ulcères plantaires chroniques du pied diabétique par botte en résine fenêtrée non amovible avec absence d’ouverture de la botte jusqu’à cicatrisation : étude prospective de 177 patients". Annals of Physical and Rehabilitation Medicine 57 (maj 2014): e382-e383. http://dx.doi.org/10.1016/j.rehab.2014.03.1391.
Martini, J., A. Hartemann, I. Lazareth i P. Léger. "Intérêt du pansement TLC-NOSF dans la prise en charge des ulcères neuro-ischémiques du pied diabétique : résultats d’une étude européenne, contrôlée, randomisée, menée en double aveugle, EXPLORER". JMV-Journal de Médecine Vasculaire 43, nr 2 (marzec 2018): 133–34. http://dx.doi.org/10.1016/j.jdmv.2017.12.132.
Ugwu, O. B., T. K. C. Udeani, C. L. Anigbo i C. S. Anigbo. "Detection of microbial pathogens colonizing foot ulcers of diabetic patients in Enugu, Nigeria". African Journal of Clinical and Experimental Microbiology 25, nr 2 (3.04.2024): 169–80. http://dx.doi.org/10.4314/ajcem.v25i2.8.
"Annexe 10 : Ulcères du pied chez le diabétique : éléments essentiels de la prise en charge". Canadian Journal of Diabetes 37 (październik 2013): S597. http://dx.doi.org/10.1016/j.jcjd.2013.07.059.
Rozprawy doktorskie na temat "Pied diabétique – Ulcères – Photothérapie":
Defrançois, Sarah. "Méthode de traitement des ulcères du pied diabétique par thérapie synergique photodynamique et photothermique à partir de matériaux polymères innovants". Electronic Thesis or Diss., Université de Lille (2022-....), 2022. https://pepite-depot.univ-lille.fr/ToutIDP/EDSMRE/2022/2022ULILR063.pdf.
Diabetes is a growing disease worldwide and will concern 12% of the adult population by 2045. This disease facilitates the development of infected lesions leading to diabetic foot ulcers (DFUs), the most common, disabling and costly complications of diabetes. In 21% of cases, these ulcerative infections are followed by amputation, which increases the risk of morbidity and mortality as well as public health costs. To prevent these dramatic outcomes, current biomedical strategies consist in physical removal of the biofilm by frequent debridement of the DFUs and/or the use of antibiotic treatments. However, these strategies have proven to be ineffective due to the rapid reformation of the biofilm and the emergence of antibiotic resistance. In this context, the objective of this work is to develop an innovative therapy based on the use of alginate hydrogels embedding functionalized polydopamine nanoparticles as nanophototherapeutic agents for the synergistic photodynamic therapy (PDT) and photothermal therapy (PDT) to treat infections caused by DFUs. To achieve this goal, the functionalization of nPDA with a photosensitizer (Ce6) allows for biofilm impairment by PDT while the photothermal properties of nPDA are exploited for on demand local release of antibiotics such as ciprofloxacin (CFX) and rifampicin (RFP). In this way, the injection of the functionalized hydrogel into the infected wound and the application of the PDT/PTT synergistic therapy will eradicate the biofilm, treat the infections by local release of the antibiotics while promoting wound healing and tissue regeneration
Patry, Jérôme. "La prise en charge de l'ulcère plantaire diabétique par une équipe interdisciplinaire spécialisée à la Clinique des plaies complexes de l'Hôtel-Dieu de Lévis". Master's thesis, Université Laval, 2020. http://hdl.handle.net/20.500.11794/69026.
Objectives: The objectives of this Master's thesis were to determine the wound healing outcomes of patients with a diabetic foot ulcer (DFU) treated with an interdisciplinary team approach at the Complex Wound Care Clinic (CWCC) of Hôtel-Dieu de Lévis Hospital of Centre intégré de santé et de services sociaux (CISSS) de Chaudière-Appalaches and to evaluate its quality of care based on recognized quality indicators. Methods: First, a retrospective observational cohort study of adult patients, with a plantar DFU, treated between 2012 and 2018 at the CWCC, was conducted. A total of 140 patients were included. Data were retrieved from electronic medical charts based on registries. Predictive and explanatory analyses were conducted with logistic multivariate regression and Receiver Operating Characteristic (ROC) curves. Second, a descriptive analysis of the quality of care was performed with an extended Donabedian model based on 22 recognized quality indicators (3 for structure, 9 for processes, 10 for outcomes). Results: About half of patients with a DFU treated with an interdisciplinary team approach healed during the first 3 months. The best predictor of wound healing at 3 months was a 41.8% wound size reduction at 4 weeks (AUC: 0.86; sensitivity: 83.1%; specificity: 67.2%, positive predictive value: 72.8%; negative predictive value: 78.9%; positive and negative likelihood ratios: 2.53 and 0.25, respectively). Main baseline variables negatively associated with this predictor were: male gender (OR 3.58, 95% CI (1.30-9.87)), cigarette smoking (OR 4.70, 95% CI (1.44-15.29)), and a monophasic Doppler waveform (OR 7.52, 95% CI (2.64-21.39)). The principal indicators regarding structure and processes were met, while outcome indicators were influenced by study population characteristics, particularly peripheral artery disease (PAD) and critical-limb ischemia. Conclusions: The health care provider should be cautious, adopt a prompt response and intensify its management of DFUs particularly with patients of male gender, smoking, having a monophasic waveform with a hand-held Doppler, and not achieving a minimal 41.8% wound area reduction at four weeks of treatment. This study suggests that DFU care at a Canadian wound care clinic with an interdisciplinary approach meets a majority of quality of care indicators. The socio-economic burden of DFUs for patients, health care organizations and policy makers, and the paucity of quality and performance evaluations call for more studies evaluating DFU care. Patient-centered performance research, especially with a patient-as-partner approach, should be integrated for a broader and complete evaluation of care.
Bou, Haidar Naila. "Développement d’un pansement à libération contrôlée d’une protéine spécifique anti-biofilm bactérien. Application aux plaies chroniques". Thesis, Normandie, 2019. http://www.theses.fr/2019NORMR087.
Bacterial biofilms are a major obstacle to the wound healing process. In addition, they are responsible for the emergence of resistance and tolerance to antibiotics. Hence, the development of controlled drug delivery systems targeting the bacterial biofilm appears as an urgent and essential alternative therapeutic approach for the effective management of chronic wound. In this work, we developed wound dressings in which a protein, dispersin B (DB), is released capable of selectively targeting the biofilm matrix, creating a deleterious microenvironment for the bacterial biofilm. To this end, we were interested in asymmetric membranes (AMs) from biodegradable polyesters such as the poly(3-hydroxybutyrate-co-4-hydroxybutyrate), the poly (butylene succinate-co-butylene adipate) (PBSA) and the polylactic acid. By the incorporation of hydrophilic porogen agents (PA), we were able to obtain AMs with a high level of porosity, exhibiting a porous interconnected network and oxygen and water vapor permeability. Using bovine serum albumin as a model protein, we demonstrated that protein loading and release from the PBSA AMs were affected by the membrane structure and the presence of residual PA. In vitro studies showed highest antibiofilm efficiency both in inhibition and dispersion (up to 80%). Normalized in vitro cytotoxicity standard assays revealed that unloaded and DB-loaded PBSA membranes met cytocompatibility criteria required for wound dressing applications